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Tetracyclic Antidepressant Causing Altered 
Biodistribution of MIBG 
Sumina R. Goel, M.D., Fabio Ponzo, M.D., and Kent P. Friedman, M.D. 
We present the case of a 61-year-old man who underwent I-123 metaiodobenzylguanidine 
(MIBG) scintigraphy based on clinical suspicion of pheochromocytoma. The study was nondiag-
nostic secondary to diffuse muscle uptake. On review of his medications, the patient was found 
to be taking mirtazapine, a tetracyclic antidepressant (Remeron). We hypothesize that the MIBG 
biodistribution was altered by mirtazapine-mediated blockade of the presynaptic alpha-2 receptor. 
To our knowledge, tetracyclic antidepressants have not been previously reported to cause altered 
biodistribution on I-123 MIBG scans.
Case Report
A 61-year-old man presented with elevated urinary 
vanillylmandelic acid levels. Pheochromocytoma was 
suspected. He underwent I-123 MIBG whole body 
scanning after 2 days of thyroid blockade with Lugol’s 
solution. Following the intravenous administration of 
314.5 megabecquerels of I-123 MIBG, planar images of 
the chest, abdomen and pelvis were acquired at 24 hours 
post injection (Fig. 1) 
On review of his medications, the patient was found 
to be on phenoxybenzamine (an alpha-blocker used to 
treat hypertension, known to not alter biodistribution 
of MIBG) and was also taking mirtazapine (a tetracyclic 
antidepressant).
Discussion
Pheochromocytoma is a rare neuroendocrine tumor, 
most commonly originating in the adrenal glands. 
Diagnosis is made by identification of abnormal plasma 
and urine metanephrine and normetanephrine levels in 
most cases. Computed tomography (CT) can identify 
95% of adrenal pheochromocytomas measuring 1 cm 
or larger. Magnetic resonance imaging (MRI) is superior 
to CT for the detection of extra-adrenal pheochromocy-
tomas [1-3]. I-123/I-131 MIBG scintigraphy detects up 
to 85% of pheochromocytomas, and is highly specific 
(95–100%) [4-6].
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Figure 1. 61-year-old man with suspected pheochromocytoma. Anterior and posterior I-123-MIBG scintigraphy at 24 hours 
demonstrates abnormal diffuse uptake of tracer throughout the muscles. No focal areas of MIBG uptake that would suggest 
pheochromocytoma are identified. 
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It is well known that MIBG biodistribution may be 
altered by labetalol, reserpine, calcium channel blockers, 
tricyclic antidepressants, sympathomimetics, cocaine, 
adrenergic neuron blockers, and some tranquilizers. 
These drugs should be discontinued one week before 
MIBG scintigraphy.
Interference of MIBG uptake by mirtazapine has 
not been previously described. Mirtazapine has a specific 
mode of action: it induces enhanced noradrenergic and 
serotonergic neurotransmission by antagonizing pre-
synaptic α2-receptors and thus blocking neurotransmit-
ter re-uptake (uptake-1 mechanism). Drugs including 
labetalol are known to block MIBG uptake via uptake-1 
inhibition and therefore it is likely that the effect of 
mirtazipine in this patient was mediated by the same 
mechanism.
This is the first known report of altered MIBG 
biodistribution secondary to a tetracyclic antidepressant 
(mirtazapine). We feel that it should be added to the list 
of drugs that interfere with MIGB scans.
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